Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NEOGENOMICS, INC.

(NEO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

NeoGenomics : Goldman Sachs Starts NeoGenomics at Buy With $55 Price Target

06/03/2021 | 06:07am EDT


© MT Newswires 2021
All news about NEOGENOMICS, INC.
07/14NEOGENOMICS : Schedules its Second Quarter 2021 Earnings Release for August 6, 2..
PU
07/07NEOGENOMICS INC : Change in Directors or Principal Officers (form 8-K)
AQ
07/07NeoGenomics, Inc. Appoints George A. Cardoza as President and Chief Operating..
CI
06/24NEOGENOMICS INC : Completion of Acquisition or Disposition of Assets (form 8-K)
AQ
06/24NeoGenomics, Inc. Announces Appointment of Clive Morris as President
CI
06/24NEOGENOMICS : Completes Inivata Acquisition - Combining Best-In-Class Liquid Bio..
PU
06/18NEOGENOMICS : Completes Inivata Acquisition - Combining Best-In-Class Liquid Bio..
PU
06/08NEOGENOMICS INC : Other Events (form 8-K)
AQ
06/07NEOGENOMICS : Insider Makes Significant Stock Sells in NeoGenomics (NEO) Shares
MT
06/04INSIDER TRENDS : NeoGenomics Insider Extends 90-Day Selling Trend
MT
More news
Financials (USD)
Sales 2021 500 M - -
Net income 2021 -59,9 M - -
Net Debt 2021 8,03 M - -
P/E ratio 2021 -91,7x
Yield 2021 -
Capitalization 5 641 M 5 641 M -
EV / Sales 2021 11,3x
EV / Sales 2022 9,67x
Nbr of Employees 1 700
Free-Float 95,8%
Chart NEOGENOMICS, INC.
Duration : Period :
NeoGenomics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEOGENOMICS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Last Close Price 46,10 $
Average target price 56,45 $
Spread / Average Target 22,5%
EPS Revisions
Managers and Directors
Mark Mallon Chief Executive Officer & Director
George A. Cardoza President & Chief Operating Officer-Lab Operations
Kathryn B. McKenzie Chief Financial Officer
Douglas M. Van Oort Executive Chairman
Steven A. Ross Chief Information Officer & Vice President
Sector and Competitors